Expression Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Visiongain has published a new report entitled Biological Drug API Manufacturing Services Market Report 2023-2033: Forecasts by Manufacturing Type...

JUPITER, Fla., Sept. 12, 2023 -- Dyadic International, Inc. , a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein...

/PRNewswire/ -- Biomarkers are a valuable tool for diagnostics, drug development, and personalised medicine. In the near future, we can expect to see an...

Date Time Could rotavirus genome be key to COVID-19 vaccine for kids? IU researchers say yes Since the pandemic struck the United States more than a year ago, Indiana University Bloomington virologist John Patton, graduate student Asha Philip and others have been working on a COVID-19 vaccine for young children, based on a well-established childhood vaccine for the common illness rotavirus. Currently, no available COVID-19 vaccines have been authorized for use in children younger than 16. John Patton. Photo by Eric Rudd, Indiana University By reverse-engineering the rotavirus genome to serve ...

Could rotavirus vaccine platforms aid in the immunization campaign against SARS-CoV-2? Rotavirus is a common diarrheal disease that affects young children. Live oral rotavirus vaccines have been used to reduce its incidence in many countries. However, with the onset of the coronavirus disease 2019 (COVID-19) pandemic, and amid focus on vaccines as the only definitive method of durable control, a new study describes the possibility of producing a combined vaccine against both infections. The study began with the generation of recombinant (r)SA11 rotaviruses, into which segment 7 modified RNAs ...